Melissa Alsina Selected Research

Panobinostat

3/2017	Deacetylase inhibitors: an advance in myeloma therapy?
1/2015	Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma.
10/2013	PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Melissa Alsina Research Topics

Disease

67	Multiple Myeloma 12/2023 - 06/2003
15	Neoplasms (Cancer) 12/2023 - 05/2004
10	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2022 - 07/2010
6	Peripheral Nervous System Diseases (PNS Diseases) 03/2017 - 07/2006
4	Plasma Cell Leukemia 10/2023 - 12/2011
4	Infections 12/2022 - 01/2012
4	Bronchiolitis Obliterans Syndrome 11/2022 - 12/2012
4	Hematologic Neoplasms (Hematological Malignancy) 09/2012 - 04/2004
3	Disease Progression 01/2022 - 07/2009
2	Cytokine Release Syndrome 10/2023 - 01/2012
2	Cytopenia 09/2023 - 12/2022
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 10/2011
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2018 - 10/2012
2	Fanconi Anemia (Fanconi's Anemia) 12/2009 - 11/2003
1	Ventricular Tachycardia 01/2023
1	Atrial Fibrillation 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Heart Failure 01/2023
1	Immunoglobulin Light-chain Amyloidosis 01/2022
1	Amyloidosis 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Cardiotoxicity 01/2018
1	Paraproteinemias (Monoclonal Gammopathy) 01/2018
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018
1	Hypoalbuminemia 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018
1	Diarrhea 03/2017
1	Fatigue 03/2017
1	Thrombocytopenia (Thrombopenia) 03/2017
1	Pathologic Complete Response 03/2016
1	Renal Insufficiency (Renal Failure) 09/2013
1	Lymphoma (Lymphomas) 09/2012
1	Stroke (Strokes) 01/2012

Drug/Important Bio-Agent (IBA)

21	Bortezomib (Velcade)FDA Link 01/2022 - 06/2003
19	Lenalidomide (CC 5013)FDA Link 01/2022 - 11/2006
17	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 11/2007
8	idecabtagene vicleucelIBA 10/2023 - 12/2022
8	carfilzomibIBA 01/2021 - 06/2012
7	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 12/2023 - 01/2023
7	Chimeric Antigen ReceptorsIBA 10/2023 - 01/2023
7	Proteasome InhibitorsIBA 01/2018 - 03/2006
7	Melphalan (Alkeran)FDA LinkGeneric 01/2017 - 11/2003
6	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 07/2010
5	Methotrexate (Mexate)FDA LinkGeneric 07/2015 - 07/2010
4	B-Cell Maturation AntigenIBA 10/2023 - 01/2023
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 10/2015
4	Sirolimus (Rapamycin)FDA Link 07/2015 - 09/2011
3	GlucocorticoidsIBA 11/2022 - 09/2011
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021 - 07/2010
3	PanobinostatIBA 03/2017 - 10/2013
3	tipifarnib (R115777)IBA 08/2005 - 05/2004
3	Farnesyltranstransferase (Farnesyltransferase)IBA 06/2005 - 09/2003
2	VaccinesIBA 11/2023 - 09/2013
2	Ferritins (Ferritin)IBA 10/2023 - 10/2023
2	ofatumumab FDA Link 11/2022 - 06/2015
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2017
2	Immunomodulating AgentsIBA 01/2018 - 10/2015
2	liposomal doxorubicin (Doxil)FDA Link 11/2015 - 01/2014
2	Thalidomide (Thalomid)FDA Link 10/2015 - 07/2004
2	Rituximab (Mabthera)FDA Link 07/2013 - 08/2011
2	Busulfan (Busulfex)FDA Link 07/2013 - 10/2011
2	DNA (Deoxyribonucleic Acid)IBA 11/2012 - 12/2009
2	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2012 - 11/2007
2	Narcotics (Narcotic Analgesics)IBA 01/2012 - 07/2010
2	tanespimycin (17AAG)IBA 06/2011 - 08/2010
1	AlbuminsIBA 12/2023
1	SurvivinIBA 11/2023
1	C-Reactive ProteinIBA 10/2023
1	ixazomibIBA 01/2023
1	Prednisone (Sone)FDA LinkGeneric 11/2022
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2022
1	IgKIBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2018
1	Vincristine (Oncovin)FDA LinkGeneric 10/2015
1	Etoposide (VP 16)FDA LinkGeneric 10/2015
1	Cisplatin (Platino)FDA LinkGeneric 10/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2015
1	1-dodecylpyridoxal (PLD)IBA 01/2014
1	AntigensIBA 09/2013
1	pomalidomideIBA 03/2013
1	Midazolam (Versed)FDA LinkGeneric 01/2013
1	Cytochrome P-450 CYP3AIBA 01/2013
1	perifosineIBA 08/2012
1	Immunoglobulin G (IgG)IBA 01/2012

Therapy/Procedure

29	Therapeutics 12/2023 - 11/2005
10	Cell Transplantation 01/2023 - 08/2011
8	Drug Therapy (Chemotherapy) 01/2017 - 06/2003
5	Transplantation 01/2022 - 07/2008
4	Homologous Transplantation 01/2023 - 10/2011
3	Hematopoietic Stem Cell Transplantation 01/2021 - 12/2011
2	Immunotherapy 05/2024 - 09/2013
2	Stem Cell Transplantation 01/2022 - 07/2004
2	Salvage Therapy 01/2013 - 10/2012
2	Drug Tapering 09/2011 - 07/2006
1	Aftercare (After-Treatment) 01/2023
1	Length of Stay 01/2023
1	Immunomodulation 01/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 09/2013